Wendy S. Arnold
Net Worth
Last updated:
What is Wendy S. Arnold net worth?
The estimated net worth of Ms. Wendy S. Arnold is at least $1,683,475 as of 6 Jul 2022. She has earned $32,365 from insider trading and has received compensation worth at least $1,651,110 in Frequency Therapeutics, Inc..
What is the salary of Wendy S. Arnold?
Ms. Wendy S. Arnold salary is $550,370 per year as Chief People Officer in Frequency Therapeutics, Inc..
How old is Wendy S. Arnold?
Ms. Wendy S. Arnold is 53 years old, born in 1972.
What stocks does Wendy S. Arnold currently own?
As insider, Ms. Wendy S. Arnold owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Frequency Therapeutics, Inc. (FREQ) | Chief People Officer | 21,186 | $0 | $0 |
What does Frequency Therapeutics, Inc. do?
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candidate is FX-322, which is in Phase IIa clinical trial to treat the underlying cause of sensorineural hearing loss. It is also developing medicines for patients across a range of degenerative conditions, including multiple sclerosis, and diseases of the muscle, gastrointestinal tract, skin, and bone. The company has a license and collaboration agreement with Astellas Pharma Inc. for the development and commercialization of FX-322, as well as collaboration and licensing agreements with Massachusetts Eye and Ear, the Massachusetts Institute of Technology, The Scripps Research Institute, and Cambridge Enterprises Limited. Frequency Therapeutics, Inc. was incorporated in 2014 and is headquartered in Lexington, Massachusetts.
Wendy S. Arnold insider trading
Frequency Therapeutics, Inc.
Ms. Wendy S. Arnold has made 6 insider trades in 2022, according to the Form 4 filled with the SEC.
The largest trade she's ever made was exercising 15,000 units of FREQ stock on 14 Feb 2022. As of 6 Jul 2022 she still owns at least 21,186 units of FREQ stock.
Frequency Therapeutics key executives
Frequency Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Mr. David L. Lucchino (56) Co-Founder, Pres, Chief Executive Officer & Director
- Mr. Peter P. Pfreundschuh (56) Chief Financial Officer
- Ms. Wendy S. Arnold (53) Chief People Officer